Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer-Reference-Cited by-同舟云学术

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

Published:2003-06-18 Issue:12 Volume:95 Page:868-878
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Draisma G.,Boer R.,Otto S. J.,van der Cruijsen I. W.,Damhuis R. A. M.,Schroder F. H.,de Koning H. J.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/95/12/868/9835198/868.pdf

Reference34 articles.

1. Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate-Specific Antigen—Based Screening

2. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer

3. Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival Rates

4. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

5. Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part II: Cause of Death Misclassification and the Recent Rise and Fall in Prostate Cancer Mortality

Cited by 890 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer;BJC Reports;2024-08-21

2. Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy;Scientific Reports;2024-08-05

3. Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry;European Urology Oncology;2024-07

4. Is It a Necessity to Revise Normal Level of Prostate-Specific Antigen in Patients with Chronic Kidney Disease?;Nephro-Urology Monthly;2024-06-08

5. Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland – A claims data analysis;European Journal of Cancer;2024-06